BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21813098)

  • 1. Conjunctival and orbital lymphoma.
    Shinder R
    Ophthalmology; 2011 Aug; 118(8):1692; author reply 1692, 1692.e1. PubMed ID: 21813098
    [No Abstract]   [Full Text] [Related]  

  • 2. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.
    Ferreri AJ; Govi S; Colucci A; Crocchiolo R; Modorati G
    Ophthalmology; 2011 Jan; 118(1):24-8. PubMed ID: 20709407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional Rituximab Injection for Low-Grade Conjunctival Lymphoma Management.
    Demirci H; Ozgonul C; Diniz Grisolia AB; Elner VM
    Ophthalmology; 2020 Sep; 127(9):1270-1273. PubMed ID: 32336490
    [No Abstract]   [Full Text] [Related]  

  • 4. Rituximab immunotherapy for ocular adnexal lymphoma: clinicopathologic correlation with 5-year follow-up.
    Sokol JA; Landau L; Lauer SA
    Ophthalmic Plast Reconstr Surg; 2009; 25(4):322-4. PubMed ID: 19617799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of conjunctival mucosa-associated lymphoid tissue lymphoma with intralesional injection of interferon alfa-2b.
    Lachapelle KR; Rathee R; Kratky V; Dexter DF
    Arch Ophthalmol; 2000 Feb; 118(2):284-5. PubMed ID: 10676800
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
    Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral conjunctival follicular lymphoma in a child.
    Wall PB; Traboulsi EI; Hsi ED; Singh AD
    J AAPOS; 2015 Apr; 19(2):183-5. PubMed ID: 25824110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional interferon-α for the treatment of bilateral conjunctival mucosa-associated lymphoid tissue lymphoma.
    Holds J; Buchanan A; Hanson R
    Pediatr Blood Cancer; 2012 Jul; 59(1):176-8. PubMed ID: 21793177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional rituximab in primary conjunctival follicular lymphoma relapsed.
    Rodríguez Villa S; Ruiz Rodríguez MJ; Vargas Pabón M
    Arch Soc Esp Oftalmol; 2017 Jul; 92(7):326-329. PubMed ID: 27986437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-lesional interferon injection for recurrent conjunctival MALT lymphoma.
    Zayed M; Sears K; Salvi SM; Rundle PA; Rennie IG; Mudhar HS
    Eye (Lond); 2013 May; 27(5):680-2. PubMed ID: 23558211
    [No Abstract]   [Full Text] [Related]  

  • 12. Conjunctival lymphoma masquerading as chronic conjunctivitis.
    Akpek EK; Polcharoen W; Ferry JA; Foster CS
    Ophthalmology; 1999 Apr; 106(4):757-60. PubMed ID: 10201599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lymphoid conjunctival tumor--clinical aspects; therapeutical options.
    Apostol S; Filip M; Nechita A; Filip A
    Oftalmologia; 2005; 49(1):26-9. PubMed ID: 15934333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extranodal marginal zone lymphoma of the ocular adnexa].
    Møller A; Specht L; Toft PB; Sjø LD
    Ugeskr Laeger; 2008 Nov; 170(45):3660-3. PubMed ID: 18986616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clarithromycin therapy of a B cell MALT lymphoma].
    Danilko L; Haas K; Schönherr U; Tschurtschenthaler G
    Ophthalmologe; 2013 May; 110(5):447-50. PubMed ID: 23224128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma.
    Peinert S; Kamel S; Seymour JF; Prince HM
    Leuk Lymphoma; 2009 Feb; 50(2):303-5. PubMed ID: 19197721
    [No Abstract]   [Full Text] [Related]  

  • 17. Conjunctival malt lymphoma successfully treated with single agent rituximab therapy.
    Salepci T; Seker M; Kurnaz E; Guler DO; Bilici A; Dane F; Aliustaoglu M; Atesoglu EB; Gumus M; Yaylaci M
    Leuk Res; 2009 Mar; 33(3):e10-3. PubMed ID: 18653234
    [No Abstract]   [Full Text] [Related]  

  • 18. Intralesional rituximab for primary iris lymphoma.
    Demirci H; Grant JS; Elner VM
    JAMA Ophthalmol; 2015 Jan; 133(1):104-5. PubMed ID: 25211092
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary conjunctival follicular lymphoma treated with the anti-CD20 antibody rituximab and low-dose involved-field radiotherapy.
    Takahira M; Okumura H; Minato H; Urushisaki N; Sakurai M; Sugiyama K
    Jpn J Ophthalmol; 2007; 51(2):149-51. PubMed ID: 17401629
    [No Abstract]   [Full Text] [Related]  

  • 20. Conjunctival extranodal marginal zone B-cell lymphoma with crystal-storing histiocytosis.
    Mittal R; Damato B; Coupland SE
    Acta Ophthalmol; 2015 Nov; 93(7):e602-3. PubMed ID: 25988528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.